Issues of fish consumption for cardiovascular disease risk reduction - PubMed (original) (raw)

Review

Issues of fish consumption for cardiovascular disease risk reduction

Susan K Raatz et al. Nutrients. 2013.

Abstract

Increasing fish consumption is recommended for intake of omega-3 (n-3) fatty acids and to confer benefits for the risk reduction of cardiovascular disease (CVD). Most Americans are not achieving intake levels that comply with current recommendations. It is the goal of this review to provide an overview of the issues affecting this shortfall of intake. Herein we describe the relationship between fish intake and CVD risk reduction as well as the other nutritional contributions of fish to the diet. Currently recommended intake levels are described and estimates of fish consumption at a food disappearance and individual level are reported. Risk and benefit factors influencing the choice to consume fish are outlined. The multiple factors influencing fish availability from global capture and aquaculture are described as are other pertinent issues of fish nutrition, production, sustainability, and consumption patterns. This review highlights some of the work that needs to be carried out to meet the demand for fish and to positively affect intake levels to meet fish intake recommendations for CVD risk reduction.

PubMed Disclaimer

References

    1. Kris-Etherton P.M., Harris W.S., Appel L.J., Committee F.T.N. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757. doi: 10.1161/01.CIR.0000038493.65177.94. - DOI - PubMed
    1. United States Department of Agriculture; Department of Health and Human Services. Dietary Guidelines for Americans, 2010. US Government Printing Office; Washington, DC, USA: 2010. - PMC - PubMed
    1. Mozaffarian D., Lemaitre R.N., King I.B., Song X., Spiegelman D., Sacks F.M., Rimm E.B., Siscovick D.S. Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: The cardiovascular health study: A cohort study. Ann. Intern. Med. 2011;155:160–170. - PMC - PubMed
    1. Mozaffarian D., Wu J.H. (n-3) fatty acids and cardiovascular health: Are effects of EPA and DHA shared or complementary? J. Nutr. 2012;142:614S–625S. doi: 10.3945/jn.111.149633. - DOI - PMC - PubMed
    1. Holub B.J., Swidinsky P., Park E. Oral docosapentaenoic acid (22:5n-3) is differentially incorporated into phospholipid pools and differentially metabolized to eicosapentaenoic acid in tissues from young rats. Lipids. 2011;46:399–407. doi: 10.1007/s11745-011-3535-3. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources